Carine Bellera

8.2k total citations · 2 hit papers
130 papers, 3.8k citations indexed

About

Carine Bellera is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Geriatrics and Gerontology. According to data from OpenAlex, Carine Bellera has authored 130 papers receiving a total of 3.8k indexed citations (citations by other indexed papers that have themselves been cited), including 57 papers in Pulmonary and Respiratory Medicine, 49 papers in Oncology and 29 papers in Geriatrics and Gerontology. Recurrent topics in Carine Bellera's work include Frailty in Older Adults (29 papers), Sarcoma Diagnosis and Treatment (25 papers) and Nutrition and Health in Aging (22 papers). Carine Bellera is often cited by papers focused on Frailty in Older Adults (29 papers), Sarcoma Diagnosis and Treatment (25 papers) and Nutrition and Health in Aging (22 papers). Carine Bellera collaborates with scholars based in France, United States and Canada. Carine Bellera's co-authors include Simone Mathoulin‐Pélissier, Pierre Soubeyran, M. Rainfray, C. Mertens, Marianne Fonck, Fleur Delva, Véronique Brouste, Antoîne Italiano, Marc Debled and Gaëtan MacGrogan and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer.

In The Last Decade

Carine Bellera

118 papers receiving 3.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Screening older cancer patients: first evaluation of the G-8 geriatric screening tool

2012 669 citations Carine Bellera, M. Rainfray et al. Annals of Oncology profile →
Screening for Vulnerability in Older Cancer Patients: The ONCODAGE Prospective Multicenter Cohort Study

2014 368 citations Pierre Soubeyran, Carine Bellera et al. profile →

Peers

Countries citing papers authored by Carine Bellera

Since Specialization

Citations

This map shows the geographic impact of Carine Bellera's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carine Bellera with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carine Bellera more than expected).

Fields of papers citing papers by Carine Bellera

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carine Bellera. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carine Bellera. The network helps show where Carine Bellera may publish in the future.

Co-authorship network of co-authors of Carine Bellera

This figure shows the co-authorship network connecting the top 25 collaborators of Carine Bellera. A scholar is included among the top collaborators of Carine Bellera based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carine Bellera. Carine Bellera is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Results of a phase Ib study of olaparib with concomitant radiotherapy in soft-tissue sarcoma: a French sarcoma group study 2025 ·Annals of Oncology ·Paul Sargos, M.-P. Sunyach, Anne Ducassou, (unknown), (unknown), Audrey Michot, Thibaud Valentin, Nelly Firmin, Jean‐Yves Blay, (unknown), Carine Bellera, Antoine Italiano	1
2	Machine Learning to Predict Mortality in Older Patients With Cancer: Development and External Validation of the Geriatric Cancer Scoring System Using Two Large French Cohorts 2025 ·Journal of Clinical Oncology ·Étienne Audureau, Pierre Soubeyran, Claudia Martinez‐Tapia, Carine Bellera, Sylvie Bastuji‐Garin, Pascaline Boudou‐Rouquette, (unknown), Thomas Grellety, Olivier Hanon, (unknown), Éléna Paillaud, Florence Canouï‐Poitrine	2
3	1925MO Regomune study: A phase II study of regorafenib + avelumab in solid tumors. Results of the radioiodine-refractory differentiated thyroid cancer (RR-DTC) 2024 ·Annals of Oncology ·(unknown), (unknown), Carine Bellera, Jean‐Philippe Guégan, Julien Hadoux, (unknown), Philippe A. Cassier, S. Hescot, (unknown), Coralie Cantarel, Jean Palussière, Michèle Kind, Isabelle Soubeyran, Alban Bessede, (unknown)	1
4	Real-World Treatment Patterns and Effectiveness of Patients With Advanced Renal Cell Carcinoma: A Nationwide Observational Study 2023 ·Clinical Genitourinary Cancer ·Laurence Albigès, Carine Bellera, (unknown), M Arnaud, Amandine Gouverneur, (unknown), Anne-Françoise Gaudin, Isabelle Durand‐Zaleski, Sylvie Négrier	1
5	Standardized Pathology Screening of Mature Tertiary Lymphoid Structures in Cancers 2023 ·Laboratory Investigation ·Lucile Vanhersecke, Antoine Bougoüin, Amandine Crombé, Maxime Brunet, Casimir Ledoux Sofeu, Marie Parrens, (unknown), Benjamin Bonhomme, (unknown), Christophe Rey, Valérie Velasco, Isabelle Soubeyran, (unknown), Alban Bessede, Carine Bellera, Jean‐Yves Scoazec, Antoîne Italiano, (unknown), Wolf H. Fridman, François Le Loarer	49
6	Anastomotic leakage and functional outcomes following total mesorectal excision with delayed and immediate colo-anal anastomosis for rectal cancer: Two single-arm phase II trials 2023 ·European Journal of Surgical Oncology ·Serge Évrard, Carine Bellera, G. Désolneux, Coralie Cantarel, (unknown), Jean‐Luc Faucheron, Michel Rivoire, Aurélien Dupré, Jean‐Yves Mabrut, Laurent Bresler, Frédéric Marchal, (unknown), Éric Rullier	3
7	Diagnostic accuracy and clinical impact of endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) in Positron Emission Tomography - Computed Tomography (PET-CT)-positive mediastinal lymphadenopathies in patients with thoracic or extra-thoracic malignancies 2022 ·Clinics and Research in Hepatology and Gastroenterology ·Dominique Béchade, Carine Bellera, (unknown), (unknown), Pippa McKelvie‐Sebileau, Marc Debled, François Chomy, Guilhem Roubaud, Marianne Fonck, Simon Pernot, (unknown), (unknown)	2
8	1494P Regomune - a phase II study of regorafenib + avelumab in solid tumors: Results of the soft tissue sarcoma (STS) cohort 2022 ·Annals of Oncology ·Sophie Cousin, Carine Bellera, (unknown), (unknown), Rastilav Bahleda, J-P. Metges, (unknown), Coralie Cantarel, Mariella Spalato Ceruso, Michèle Kind, Isabelle Soubeyran, Jean Palussière, (unknown), Antoine Italiano	3
9	Regorafenib-Avelumab Combination in Patients with Microsatellite Stable Colorectal Cancer (REGOMUNE): A Single-arm, Open-label, Phase II Trial 2021 ·Clinical Cancer Research ·Sophie Cousin, Coralie Cantarel, Jean‐Philippe Guégan, Carlos Gomez‐Roca, Jean‐Philippe Metges, Antoine Adenis, Simon Pernot, Carine Bellera, Michèle Kind, Céline Auzanneau, François Le Loarer, Isabelle Soubeyran, Alban Bessede, Antoîne Italiano	95
10	Time to next treatment or death as a candidate surrogate endpoint for overall survival in advanced melanoma patients treated with immune checkpoint inhibitors: an insight from the phase III CheckMate 067 trial 2021 ·ESMO Open ·(unknown), Casimir Ledoux Sofeu, Anne-Françoise Gaudin, Murat Kurt, Andriy Moshyk, Antoîne Italiano, Carine Bellera, Virginie Rondeau	12
11	Machine Learning and Mechanistic Modeling for Prediction of Metastatic Relapse in Early-Stage Breast Cancer 2020 ·JCO Clinical Cancer Informatics ·Chiara Nicolò, C. Périer, Mélanie Prague, Carine Bellera, Gaëtan MacGrogan, Olivier Saut, Sébastien Benzekry	45
12	Activity and Safety of Palbociclib in Patients with Advanced Gastrointestinal Stromal Tumors Refractory to Imatinib and Sunitinib: A Biomarker-driven Phase II Study 2019 ·Clinical Cancer Research ·Maud Toulmonde, Jean‐Yves Blay, Olivier Bouché, Olivier Mir, Nicolas Penel, Nicolás Isambert, Florence Duffaud, Emmanuelle Bompas, (unknown), Romain Boidot, (unknown), François Ghiringhelli, Carlo Lucchesi, Carine Bellera, François Le Loarer, Antoîne Italiano	14
13	Immune-checkpoint inhibitors and candidate surrogate endpoints for overall survival across tumour types: A systematic literature review 2019 ·Critical Reviews in Oncology/Hematology ·(unknown), Carine Bellera, Antoîne Italiano, (unknown), Anne-Françoise Gaudin, Virginie Rondeau	14
14	The prognostic value of G8 for functional decline 2019 ·Journal of Geriatric Oncology ·Camille Chakiba, Carine Bellera, (unknown), Simone Mathoulin‐Pélissier, M. Rainfray, Pierre Soubeyran	17
15	Modeling individual and relative accuracy of screening tools in geriatric oncology 2017 ·Annals of Oncology ·Carine Bellera, Fanny Artaud, M. Rainfray, Pierre Soubeyran, Simone Mathoulin‐Pélissier	8
16	A two-stage model in a Bayesian framework to estimate a survival endpoint in the presence of confounding by indication 2016 ·Statistical Methods in Medical Research ·Carine Bellera, Cécile Proust‐Lima, Lawrence Joseph, Pierre Richaud, Jeremy M. G. Taylor, Howard M. Sandler, James A. Hanley, Simone Mathoulin‐Pélissier	2
17	Shared random-effect models for the joint analysis of longitudinal and time-to-event data: application to the prediction of prostate cancer recurrence 2014 ·HAL (Le Centre pour la Communication Scientifique Directe) ·(unknown), Carine Bellera, Cécile Proust‐Lima	8
18	Functional Decline in Older Patients With Cancer Receiving First-Line Chemotherapy 2013 ·Journal of Clinical Oncology ·Stéphanie Hoppe, M. Rainfray, Marianne Fonck, (unknown), Jean‐Frédéric Blanc, J. Ceccaldi, C. Mertens, C. Blanc-Bisson, Y. Imbert, Laurent Cany, (unknown), Jérôme Dauba, Nadine Houédé, Carine Bellera, Anne Floquet, (unknown), Alain Ravaud, Camille Chakiba, Simone Mathoulin‐Pélissier, Pierre Soubeyran	174
19	Diagnostic accuracy of (18) F-FDG PET/CT for the detection of peritoneal carcinomatosis of colorectal origins 2013 ·(unknown), E. Descat, F. Bonichon, (unknown), Carine Bellera, Serge Évrard, (unknown)	2
20	Predictors of Early Death Risk in Older Patients Treated With First-Line Chemotherapy for Cancer 2012 ·Journal of Clinical Oncology ·Pierre Soubeyran, Marianne Fonck, C. Blanc-Bisson, Jean‐Frédéric Blanc, J. Ceccaldi, C. Mertens, Y. Imbert, Laurent Cany, (unknown), Jérôme Dauba, Francis Andriamampionona, Nadine Houédé, Anne Floquet, François Chomy, Véronique Brouste, Alain Ravaud, Carine Bellera, M. Rainfray	305

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact